Skip to main content
Market intelligence
RVMDHealthcare

Revolution Medicines Inc insider activity

In the last 90 days, no corporate insiders reported open-market purchases.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Jun 24, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Jun 24, 2026Jack AndersChief Financial OfficerSale20,000$168.33$3,366,604
Jun 17, 2026Margaret A HornChief Operating OfficerSale93,575$160.00$14,972,112
Jun 16, 2026Anthony ManciniSee RemarksSale4,615$156.12$720,490